Evidence map›Paper›PMID 29047177›Full record

ReviewPhytotherapy research : PTR2018

Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions.

Muhammad Ali, Tariq Khan, Kaneez Fatima, Qurat Ul Ain Ali, Muhammad Ovais, Ali Talha Khalil, Ikram Ullah, Abida Raza, Zabta Khan Shinwari, Muhammad Idrees

Open access · bronzeAbstract readReview
In one paragraph

Review in Phytotherapy research : PTR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 153 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Journal of Taibah University Medical Sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Muhammad AliDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.ORCID http://orcid.org/0000-0002-7835-0663
Tariq KhanDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.
Kaneez FatimaDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.
Qurat Ul Ain AliDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.
Muhammad OvaisDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.
Ali Talha KhalilDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.
Ikram UllahDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.
Abida RazaNational Institute of Laser and Optronics, Nilore, 45650, Pakistan.
Zabta Khan ShinwariDepartment of Biotechnology, Quaid-i-Azam University Islamabad, Islamabad, 45320, Pakistan.
Muhammad IdreesHazara University Mansehra, Khyber Pakhtunkhwa, 21120, Pakistan.
Quaid-i-Azam University · PKPakistan Institute of Nuclear Science and Technology · PKUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insight into the hepatoprotective effects of medicinally important plants is important, both for physicians and researchers. Main reasons for the use of herbal medicine include their lesser cost compared with conventional drugs, lesser undesirable drug reactions and thus high safety, and reduced side effects. The present review focuses on the composition, pharmacology, and results of experimental trials of selected medicinal plants: Silybum marianum (L.) Gaertn., Glycyrrhiza glabra, Phyllanthus amarus Schumach. & Thonn., Salvia miltiorrhiza Bunge., Astragalus membranaceus (Fisch.) Bunge, Capparis spinosa (L.), Cichorium intybus (L.), Solanum nigrum (L.), Sapindus mukorossi Gaertn., Ginkgo biloba (L.), Woodfordia fruticosa (L.) Kurz, Vitex trifolia (L.), Schisandra chinensis (Turcz.) Baill., Cuscuta chinensis (Lam.), Lycium barbarum, Angelica sinensis (Oliv.) Diels, and Litsea coreana (H. Lev.). The probable modes of action of these plants include immunomodulation, stimulation of hepatic DNA synthesis, simulation of superoxide dismutase and glutathione reductase to inhibit oxidation in hepatocytes, reduction of intracellular reactive oxygen species by enhancing levels of antioxidants, suppression of ethanol-induced lipid accumulation, inhibition of nucleic acid polymerases to downregulate viral mRNA transcription and translation, free radical scavenging and reduction of hepatic fibrosis by decreasing the levels of transforming growth factor beta-1, and collagen synthesis in hepatic cells. However, further research is needed to identify, characterize, and standardize the active ingredients, useful compounds, and their preparations for the treatment of liver diseases.

Indexed as

AnimalsDrugs, Chinese HerbalHerbal MedicineLiver DiseasesMedicine, TraditionalModels, AnimalPhytotherapyDrugs, Chinese HerbalHepatitis Chepatoprotective activityherbalmedicinal plantstreatment

Identifiers

PMID29047177
PMCPMC7167792
OpenAlexW2765805888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.